1718.7000 -13.10 (-0.76%)
NSE May 22, 2025 15:31 PM
Volume: 2.7M
 

Axis Direct
Sun Pharma: Dual play on US Recovery & growth in IPM, Resolution of Halol plant a key trigger; Godrej Consumer Products: Diverse Portfolio, focused on innovation, Dual play on Domestic and Emerging Markets
Sun Pharmaceutical I.. has an average target of 2054.00 from 8 brokers.
More from Sun Pharmaceutical Industries Ltd.
All Rapid Results
Recommended